(Q39752057)

English

Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

phase II clinical trial

0 references

pantothenate kinase-associated neurodegeneration

0 references

magnetic resonance imaging

0 references

neurodegeneration

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Domenico Aquino

9

0 references

7

0 references

Luisa Chiapparini

3

0 references

Barbara Garavaglia

object named as

Barbara Garavaglia

8

0 references

author name string

Giovanna Zorzi

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Federica Zibordi

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Lidia Russo

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Antonio Piga

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Mario Savoiardo

10

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Alessandra Solari

11

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Nardo Nardocci

12

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

0 references

publication date

6 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1756-1759

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

Iron: a new target for pharmacological intervention in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

Selective iron chelation in Friedreich ataxia: biologic and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

Rating scales for dystonia: a multicenter assessment.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

The Italian SF-36 Health Survey: translation, validation and norming

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

Iron accumulation in syndromes of neurodegeneration with brain iron accumulation 1 and 2: causative or consequential?

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

Iron in chronic brain disorders: imaging and neurotherapeutic implications

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

Brain iron homeostasis and neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

Iron misregulation in the brain: a primary cause of neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23751

21 January 2018

Identifiers

10.1002/MDS.23751

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39752057&oldid=2165717024"